Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ENSC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 58 days ago
Red flags: 4
16 filers reported a long position in ENSC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| JANE STREET GROUP, LLC | $60.6K | 208.8K | +1,438.9% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $43.4K | 149.7K | Unchanged |
| Virtu Financial LLC | $28K | 95.4K | +616.5% |
| PERCEPTIVE ADVISORS LLC | $25.1K | 86.7K | Unchanged |
| CITADEL ADVISORS LLC | $25K | 86.2K | +50.3% |
| XTX Topco Ltd | $22.3K | 77K | +216.1% |
| GEODE CAPITAL MANAGEMENT, LLC | $18K | 62.2K | -15.8% |
| HRT FINANCIAL LP | $15K | 54.4K | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.9K | 34.3K | New |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | $3.8K | 13K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.